CNVVF (Convatec Group) Beta: 1.0599 (As of Jun. 24, 2026)


CNVVF Convatec Group PLC CNVVF
77 GF Score
Price $2.73
GF Value $3.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group Beta?

Convatec Group CNVVF 77 Beta is 1.0599 as of Jun. 24, 2026. GuruFocus rates CNVVF with a GF Score™ of 77/100 and a GF Value™ of $3.08 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Convatec Group's Beta is 1.0599.


Convatec Group  (OTCPK:CNVVF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Convatec Group Beta Related Terms


Convatec Group Beta Historical Data

* Premium members only.

The historical data trend for Convatec Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group Beta Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.22 0.37 0.49 0.92

Convatec Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.45 0.49 0.55 0.92

CNVVF vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Convatec Group Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Beta distribution charts can be found below:

* The bar in red indicates where Convatec Group's Beta falls into.


CNVVF
77GF Score
Convatec Group PLC CNVVF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.0599 mean?
Convatec Group (CNVVF) has a Beta of 1.0599 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Convatec Group and its competitors.
Is Convatec Group's Beta too high?
Convatec Group's current Beta is 1.0599. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Beta compare to ISRG and BDX?
Convatec Group's Beta of 1.0599 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Convatec Group and its competitors. Convatec Group's current Beta is 1.0599. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (CNVVF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.08, compared to a current price of $2.73 — trading 11.4% below its estimated fair value. The current Beta is 1.0599. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Convatec Group (CNVVF), the current Beta is 1.0599 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (CNVVF) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of $2.73 is trading 11.4% below its estimated GF Value™ of $3.08. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for CNVVF:

  • Beta: 1.0599
  • GF Value™: $3.08 vs. price of $2.73 (11.4% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the CNVVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for CNVVF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.73
Price
$3.08
GF Value